Volume 53, Issue 6, Pages (June 2008)

Slides:

Advertisements

Similar presentations

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Advertisements

Volume 155, Issue 3, Pages (March 1996)

The PSA Era is not Over for Prostate Cancer

Volume 50, Issue 1, Pages (July 2006)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Volume 58, Issue 4, Pages (October 2010)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 61, Issue 6, Pages (June 2012)

Claude C. Schulman, Jacques Irani, Juan Morote, Jack A

Volume 60, Issue 5, Pages (November 2011)

Volume 53, Issue 5, Pages (May 2008)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 69, Issue 1, Pages (January 2016)

Volume 65, Issue 5, Pages (May 2014)

Volume 60, Issue 6, Pages (December 2011)

Volume 71, Issue 5, Pages (May 2017)

Hormone Therapy for Prostate Cancer: Exploring Current Controversies

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Prostate Cancer Epidemic in Sight?

Volume 72, Issue 5, Pages (November 2017)

Volume 74, Issue 4, Pages (October 2018)

Volume 61, Issue 1, Pages (January 2012)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 68, Issue 4, Pages (October 2015)

Volume 71, Issue 1, Pages 1-3 (January 2017)

Volume 61, Issue 5, Pages (May 2012)

What is New in Hormone Therapy for Prostate Cancer in 2007?

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Volume 74, Issue 1, Pages (July 2018)

Volume 67, Issue 3, Pages (March 2015)

Volume 67, Issue 6, Pages (June 2015)

Volume 64, Issue 3, Pages (September 2013)

Volume 71, Issue 5, Pages (May 2017)

Localised and Locally Advanced Prostate Cancer: Who to Treat and How?

Laurent Boccon-Gibod European Urology Supplements

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 2, Pages (February 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

External Beam Radiotherapy as Curative Treatment of Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 6, Pages (June 2008)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care Fred Saad, Carl Olsson, Claude C. Schulman

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial

Volume 50, Issue 5, Pages (November 2006)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Volume 71, Issue 5, Pages (May 2017)

Jacques Irani European Urology Supplements

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Long-Term Hormonal Therapy: Who Would Benefit?

European Urology is “Your” Journal

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Volume 54, Issue 2, Pages (August 2008)

Volume 54, Issue 1, Pages (July 2008)

Management of Prostate Cancer: Global Strategies

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 53, Issue 6, Pages 1172-1179 (June 2008) Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer Michael J. Zelefsky, Yoshiya Yamada, Marisa A. Kollmeier, Alison M. Shippy, Michelle A. Nedelka European Urology Volume 53, Issue 6, Pages 1172-1179 (June 2008) DOI: 10.1016/j.eururo.2007.12.030 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Biochemical progression-free survival for patients treated with neoadjuvant and concurrent androgen-deprivation therapy who received higher (≥75Gy) doses versus lower doses. European Urology 2008 53, 1172-1179DOI: (10.1016/j.eururo.2007.12.030) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Local progression-free survival rate for patients treated with and without androgen-deprivation therapy. European Urology 2008 53, 1172-1179DOI: (10.1016/j.eururo.2007.12.030) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 Distant metastases-free survival outcomes for patients treated to ≥8100cGy in conjunction with neoadjuvant and concurrent androgen-deprivation therapy, T3a versus T3b patients. European Urology 2008 53, 1172-1179DOI: (10.1016/j.eururo.2007.12.030) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 4 Cause-specific survival outcomes for patients treated to ≥8100cGy in conjunction with neoadjuvant and concurrent androgen-deprivation therapy, T3a versus T3b patients. European Urology 2008 53, 1172-1179DOI: (10.1016/j.eururo.2007.12.030) Copyright © 2007 European Association of Urology Terms and Conditions